Silicone Breast Implants

American College of Obstetricians and Gynecologists. (1992). Professional liability and its effects: Report of a 1992 Survey of ACOG's membership (p. 31).

American Cancer Society, et al. (1996). Citizen petition to the Docket Management Branch, FDA, September 19.

American College of Rheumatology. (1996). Updated silicone breast implant statement, July 9.

American Medical Association, Council on Scientific Affairs. (1993). Silicone gel breast implants. JAMA, 270(21), 2602–2606.

Angell M. (1996a). Science on trial: The clash of medical evidence and the law in the breast implant case. New York: W.W. Norton & Company, Inc.

Angell M. (1996b). Shattuck lecture—Evaluating the health risks of breast implants: The interplay of medical science, the law, and public opinion. New England Journal of Medicine, 334(23), 1513–1518.

Aronoff Associates. (1997). Biomaterials availability: A vital health care industry hangs in the balance. Report prepared for the Health Industry Manufacturers Association, April.

Brigham and Women's Hospital. (1996). Study finds breast implants do not pose large risk of connective tissue disease. Press Release, February 28.

Bryant K. (1995). Liability and its impact on women. Address given at Society for the Advancement of Women's Health Research Corporate Advisory Council Meeting.

Connell E. (1995). Congressional testimony before a joint hearing of the House Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources and Regulatory Affairs, August 1.

Ferguson J.H. (1997). Silicone breast implants and neurologic disorders. Report of the Practice Committee of the American Academy of Neurology. Neurology, 48(6), 1504–1507.

Food and Drug Administration. (1997a). Breast implants: An information update. pp. 1, July, http://www.fda.gov/oca/hotopics/htm.

Food and Drug Administration (1997b). Letter from Michael A. Friedman, MD, lead deputy comissioner, FDA, to Rosemary Locke, Y-ME National Breast Cancer Organization. Re: Citizen's petition, docket number 96P-0337/CP-1, October 15.

Friis S. Mellemkjær L. McLaughlin J. Breiting V. Kjær S. Blot W. , & Olsen J. (1997). Connective tissue disease and other rheumatic conditions following breast implants in Denmark. Annals of Plastic Surgery, 39(1), 1–8.

Gabriel S.E. O'Fallon W.M. Kurland L.T. Beard C.M. Woods J.E. , & Melton L.J. (1994). Risk of connective-tissue diseases and other disorders after breast implantation. New England Journal of Medicine, 330(24), 1697–1702.

Greenberger P. (1995). Congressional testimony, U.S. Senate, January 31.

Health Industry Manufacturers Association. (1996). Statement on biomaterials legislation, September 18.

Hennekens C.H. Lee I.M. Cook N.R. Hebert P.R. Karlson E.W. LaMotte F. Manson J.E. , & Buring J.E. (1996). Self-reported breast implants and connective-tissue diseases in female health professionals: A retrospective cohort study. JAMA, 275(8), 616–621.

Independent Women's Forum. (1997). Case study on Norplant contained in the IWF conference program: In brief – women's health, law, and the junking of science. Washington, D.C., February 20.

Institute of Medicine, Committee on Contraceptive Research and Development. (1996). Contraceptive research and development: Looking to the future. Harrison P.F. & Rosenfield A. (Eds.). Washington, D.C.

Kahanovitz N. (1997). Center for Patient Advocacy. Congressional testimony, Committee on the Judiciary, Subcommittee on Commercial and Administrative Law, June 12.

Kent K. (1997). Congressional testimony, U.S. House of Representatives, June 12.

PBS “Frontline.” (1996). Breast implants on trial. February 27.

Petition to Congress. (1997). A shortage of medical biomaterials threatens the supply of implants. We need Congress' help. Signers included representatives from the Center for Patient Advocacy, American College of Cardiology, Society for the Advancement of Women's Health Research, American Society for Artificial Internal Organs, Society of Cardiovascular and Interventional Radiology, The Hydrocephalus Research Foundation, Society for Biomaterials, Society of Thoracic Surgeons, and Health Industry Manufacturers Association. April 11.

Sanchez-Guerrero J. Colditz G.A. Karlson E.W. Hunter D.J. Speizer F.E. , & Liang M.H. (1995). Silicone breast implants and the risk of connective-tissue diseases and symptoms. New England Journal of Medicine, 332(25), 1666–1670.

U.K. Medical Devices Agency. (1997). Silicone gel breast implants: Summary of the current situation. April.

U.S. Public Health Service, Office on Women's Health. Fact sheet: Autoimmune disease in women. http://www.4woman.org/owh/aboutowh/fsautoimm.htm.

Vincent J.L. (1993). Testimony before the U.S. Senate Commerce Committee (September 23). American Tort Reform Association Fact Sheet.